In India as well, the companies have filed leniency applications with the competition watchdog
The Supreme Court on Thursday upheld the Competition Appellate Tribunal's (Compat's) order quashing a penalty of Rs 64 crore imposed by the Competition Commission of India (CCI) on multinational drug makers GlaxoSmithKline and Sanofi Pasteur for alleged bid rigging to supply vaccines for Haj pilgrims. The two companies were accused of colluding in bids for the Quadrivalent Meningococcal Meningitis Vaccine in tenders floated by the Union health ministry. GSK and Sanofi Pasteur had first appealed to Compat. A lawyer on the case told Business Standard that the apex court decided the facts and figures did not make for a judgement against the pharma majors. A lawyer for CCI argued it had evidence that the companies had engaged in tender rigging, that the quantity of bids by GSK and Sanofi together was equivalent to the tender quantity. CCI did not satisfy the standard of proof required of it, the court observed.Earlier, Compat had also quashed the CCI's order, deciding there was no ...
The Supreme Court has upheld an order by the Competition Appellate Tribunal (Compat) that penalties imposed by the Competition Commission of India (CCI) on companies should be only on the turnover relevant to a case in dispute, not their overall turnover. The apex court's decision came on Monday on an appeal by CCI against Compat reducing the penalty it had imposed on Excel Crop, United Phosphorus and Sandhya Organic Chemicals, for an anti-competitive agreement between them that raised the cost of procurement of Aluminium Phosphide tablets by Food Corporation of India. CCI had imposed a penalty of nine per cent of the average three-years' turnover of each of these companies. This amounted to Rs 63.9 crore on Excel, Rs 252.44 crore on United Phosphorus and Rs 1.57 crore on Sandhya Organic. While Compat upheld the charge against the companies, it decided the competition regulator had wrongly calculated the penalties on the basis of overall turnover. Excel and United Phosphorus had ...
The Competition Commission has approved the proposed acquisition of Johnson & Johnson's two brands, 'Savlon' and 'Shower to Shower', by FMCG major ITC. Savlon is an antiseptic brand while Shower To Shower is a personal care product brand. In a tweet today, the Competition Commission of India (CCI) said that it has approved "acquisition of Savlon and Shower to Shower brands by ITC". According to the notice submitted to CCI, ITC would acquire Savlon with "certain attendant inventories, know-how, molds and promotional materials" from Johnson & Johnson Private Ltd. The FMCG major would also acquire the Shower to Shower brand along with "certain know-how and promotional materials" from Johnson & Johnson PTE. ITC is a multi-business enterprise having presence in fast moving consumer goods (FMCG), hotels, agri-business, among others. Johnson & Johnson Private Ltd and Johnson & Johnson PTE are part of US-based Johnson & Johnson Inc, which .
This has been established from quoting of unusually higher rates in the impugned tender of cement
One case has been registered by Reliance Jio against other operators and two cases have been registered against Jio
Out of the penalty imposed, a total of Rs 10,454.08 crore have been stayed by the CAT and various courts
The body also said it had approved the proposed restructuring of Fortis Group
Under the chairmanship of former Competition Commission of India (CCI) Chairman Ashok Chawla, the ministry of corporate affairs has constituted an expert panel to examine various issues related to audit firms, including possible adverse impact from restrictive shareholder agreements.The panel would examine whether joint audit could be introduced in cases where there are restrictive covenants and other specified cases where there is a multinational audit firm as the auditor. This expert committee has been asked to submit its report within two months, according to the order issued on the 30 September.
As part of efforts to expand its non-banking finance business, IIFL Group, in July, roped in CDC Group
These 24 entities would be carrying out their activities as competition resource person
Fair trade regulator Competition Commission of India (CCI) is looking to hire over 30 people for various director-level positions, as part of its efforts to address manpower crunch.
It was alleged that there were unfair conditions in the tender notice, floated by the CIMFR
It was alleged that these entities indulged in anti- competitive practices in the digital cinema exhibition market
The REC will have to secure work in the market for consultancy services for financing of rural electrification projects
In a huge win for the Competition Commission of India (CCI), the Delhi High Court on Wednesday upheld its jurisdiction to investigate patent-related competition matters. The regulator would now be able to freely investigate and pass orders in the cases filed by Micromax and Intex against Ericsson, alleging abuse of dominance in the market of technology patents."Merely because certain reliefs sought by Micromax and Intex before CCI are also available in proceedings under the Patents Act does not exclude the subject matter of the complaints from the scope of the Competition Act. An abuse of dominant position under Section 4 of the Competition Act is not a cause that can be made a subject matter of a suit or proceedings before a civil court," said the court.According to sources, Ericsson would now be taking this case to the division bench of the high court or to the Supreme Court. "We are reviewing the court's order. We do not have any comments at this point in time," said an Ericsson sp
The latest changes will help in the government's agenda towards ease of doing business
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report